Radiological features of the hepatic castleman disease (HCD): A case report and literature review

  • Lê Đức Nam Bệnh viện Hữu Nghị
  • Vũ Lê Minh Bệnh viện K Tân Triều
  • Nguyễn Quốc Đạt Bệnh viện K Tân Triều
  • Đinh Hoàng Việt Bệnh viện K Tân Triều
  • Bùi Văn Giang Bệnh viện K Tân Triều
  • Nguyễn Quốc Dũng Bệnh viện Medlatec

Main Article Content

Keywords

Hepatic Castleman disease (HCD), lymph node hyperplasia, hyaline-vascular type, plasma cell type

Abstract

Hepatic Castleman disease (HCD) is very rare disease characterized by lymph node hyperplasia and that is easy to mimics with other hepatic mass. We report a 24 year-old male with chronic hepatitis B visited Vietnam National Cancer Hospital with right upper quadrant discomfort. Ultrasound and computer tomography showed a giant right hepatic tumor. Hepatocellular carcinomar (HCC) was suspected. Biomarkers for liver cancer (aFP, CEA, CA 19-9) was normal. After ultrasound-guided liver biopsy, histopathology revealed Castleman’s disease. We report a case of HCD and review its pathological and imaging characteristics of 18 cases in 17 papers of hepatic Castleman's disease published in the US National Library (Pubmed) and the ScienceDirect database of Elsevier publishers. The results of the literature review showed the hepatic Castleman disease characteristics: With 19 patients (14 women and 5 men), out case and 18 patients in database review, women and men ratio was 2.8, with mean age of 48.3 ± 16.2 years (range, 24-70 years). The most common age of hyaline - vascular type was 20-40 years old (85.7%). There was correlation between the age and histopathological type (p=0.017). Most patients who came to the hospital was no symptom. Radiological features: The most common of mass was well - define in the hilum (89.5%). On abdominal ultrasound, hypoechoic mass was in 80% of all case and 61.5% of hyaline vascular type, there was correclation between the echoic mass and histopathological type (p=0.049). On CT, mass showed hypodense on non – enhancement phase (61.3%), hypervascular in the arterial phase (88.2%), isodense on portal venous phase (46.7%). There was no correlation between the CT features and histopathological type (p=0.314).

Article Details

References

1. Castleman B, Towne VW (1954) Case records of the Massachusetts General Hospital, weekly clinicopathological exercises. Founded by Richard C. Cabot. N Engl J Med 251(10): 396-400. doi: 10.1056/NEJM195409022511008.
2. Keller AR, Hochholzer L, Castleman B (1972) Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 29(3): 670-683. doi: 10.1002/1097-0142(197203)29:3<670::AID-CNCR2 820290321>3.0.CO;2-#.
3. Yamagata N, Fujio J, Hirai R et al (2006) Marked hepatomegaly due to AA type amyloidosis in a case with Castleman’s disease. Int J Hematol 84(1): 70-73. doi:10.1532/IJH97.05126.
4. Rahmouni A, Golli M, Mathieu D, Anglade MC, Charlotte F, Vasile N (1992) Castleman disease mimicking liver tumor: CT and MR features. J Comput Assist Tomogr 16(5): 699-703. doi:10.1097/00004728-199209000-00005.
5. Cirillo RL (1998) Castleman disease mimicking a hepatic neoplasm. Clin Imaging 22(21): 24-29. doi:10.1016/s0899-7071(97)00096-x.
6. Uzunlar AK (2000) Castleman’s disease in the porta hepatis. Eur Radiol 10(12): 1913-19155. doi:10.1007/s003300000515.
7. Jang SY, Kim BH, Kim JH, Ha SH, Hwang JA, Yeon JW, Kim KH, Paik SY (2012) A case of Castleman’s disease mimicking a hepatocellular carcinoma: A case report and review of literature. Korean J Gastroenterol 59: 153-157. doi:10.4166/kjg.2012. 59.1.53.
8. Miyoshi H, Mimura S, Nomura T, Tani J, Morishita A, Kobara H, Mori H, Yoneyama H, Deguchi A, Himoto T, Yamamoto N, Okano K, Suzuki Y, Masaki T (2013) A rare case of hyaline-type Castleman disease in the liver. World J Hepatol 27(57): 404-408. doi: 10.4254/wjh.v5.i7.404.
9. Dong A, Dong H, Zuo C (2014) Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT. Clin Nucl Med 39(1): 69-72. doi: 10.1097/RLU.0b013e 31827a25fd.
10. De Vito C, Papathomas G T, Pedica F, Kane P, Amir A, Heaton N, Quaglia A (2019) Synchronous unicentric castleman disease and inflammatory hepatocellular adenoma: A case report. Ann Hepatol 18(1): 263-268. doi: 10.5604/01.3001.0012.7936.
11. Sweed D, Abdelhalim H, Fayed Y et al (2020) Post direct acting anti-viral agents associated primary hepatic Castleman’s disease: A case report. Ann Med Surg. 58: 37-40. doi: 10.1016/j.amsu.2020.08.019.
12. Lv K, Zhang CL, Xu MS (2018) Primary Castleman’s disease in the liver: A case report and literature review. Mol Clin Oncol 8(4): 575-578. doi: 10.3892/mco.2018.1576.
13. Maundura M, Hayward G, McKee C, Koea JB (2017) Primary castleman’s disease of the liver. J Gastrointest Surg 21(2): 417-419. doi: 10.1007/s11605-016-3227-7.
14. Sato N, Kondo S, Saito K et al (2006) Hyaline vascular-type castleman’s disease in the hepatoduodenal ligament: Report of a case. Surg Today 36(7): 647-650. Doi: 10.1007/s00595-006-3200-2.
15. Xu XY, Liu XQ, Du HW, Liu JH (2019) Castleman disease in the hepatic-gastric space: A case report. World J Clin Cases 7(24): 4391-4397. doi: 10.12998/wjcc.v7.i24.4391.
16. Im YR, Dong J, Paterson AL, Harper S, Peters J (2021) Autoimmunity due to unicentric castleman disease cured by resection of a hepatic mass. JCR J Clin Rheumatol. 27(1): 32. doi: 10.1097/RHU. 0000000000001226.
17. Dai B, Yang F, Zhang W et al (2020) Primary castleman’s disease in the hepatis caudate lobe: A case report. In Review doi: 10.21203/rs.3.rs-38759/v1.
18. Han HY, Kim JH, Kang DW, Case of hepatic Castleman’s disease presenting as a malignancy: Challenging diagnosis and literature review. Nt J Clin Exp Med: 6.
19. Serpa LF, Cueva M, Flores E, Molina GA, Yu Lee A, Serpa Carmoma F (2021) Castleman’s disease: Laparoscopic resection of unicentric disease in the hepatic hilum: A case report. Ann Med Surg 67: 102494. doi:10.1016/j.amsu.2021.102494.
20. Talat N, Belgaumkar AP, Schulte KM (2012) Surgery in castleman’s disease: A systematic review of 404 published cases. Ann Surg 255(4): 677-684. doi:10.1097/SLA.0b013e318249dcdc.
21. Bonekamp D, Horton KM, Hruban RH, Fishman EK (2011) Castleman disease: the great mimic. Radiogr Rev Publ Radiol Soc N Am Inc 31(6): 1793-1807. doi:10.1148/rg.316115502.
22. Zhang X, Rao H, Xu X et al (2018) Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients. Cancer Sci 109(1): 199-206. doi: 10.1111/cas.13439.
23. McAdams HP, Rosado-de-Christenson M, Fishback NF, Templeton PA (1998) Castleman disease of the thorax: radiologic features with clinical and histopathologic correlation. Radiology 209(1): 221-228. doi: 10.1148/radiology.209.1.9769835.
24. Cronin DMP, Warnke RA (2009) Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol 16(4): 236-246. doi: 10.1097/PAP.0b013e3181a9d4d3.